Pfizer and GSK to work together on continuous manufacturing

GlaxoSmithKline ($GSK) and Pfizer ($PFE) have both been working on incorporating continuous manufacturing into their production networks. Now they will work on it together. Pfizer announced today that the two had inked a multi-year collaboration for the next-gen design of the portable, continuous, miniature and modular (PCMM) prototype for oral solid dose production that it has already built. Pfizer acknowledged that GSK, which is incorporating continuous manufacturing into a plant in Singapore, has expertise in the field. Release | More

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)